KIAA1429 knockdown may suppress OS progression by inhibiting m6A-dependent SLC7A11 expression, thereby promoting ferroptosis and targeting the KIAA1429/SLC7A11 axis may represent a promising therapeutic strategy for OS.
Hui Zeng, Yun-Yan Zhong, Ding-Biao Zeng et al.· International Journal of Onc...· 0 citations
HIST1H4L was significantly upregulated in SCLC tumors versus normal tissues and enriched in DNA transcription-related pathways and correlated with poor patient survival; critically, high HIST1H4L expression correlated with poor patient survival.
Shi-Cheng Feng, Min Feng, Zhi-Qiang Lu et al.· Frontiers in Oncology· 0 citations
Clinically, these findings identify the METTL1/USP48/LCN2 pathway as a potential therapeutic target for cSCC and elucidated a novel oncogenic axis in cSCC, wherein METTL1 stabilized USP48 mRNA through m7G methylation modification, and USP48 in turn deubiquitinated and stabilized LCN2 protein.
Xiu-Qi Li, Lin Shu, Xiao-Qiang Li et al.· Applied Biochemistry and Bio...· 0 citations
Prostate cancer (PCa) is a widespread malignancy with poor prognosis in advanced stages. However, the role of long non-coding RNA (lncRNA) HNF1A-AS1 in PCa progression and its underlying mechanisms remain largely unclear. This study aims to explore the expression trends and clinical associations of HNF1A-AS1 in PCa, an...
Lymphangiogenesis significantly contributes to poor prognosis and reduced survival in oral squamous cell carcinoma (OSCC) patients due to lymphatic metastasis. Despite the critical role of N6-methyladenosine (m
6
A)—the most abundant eukaryotic mRNA modification—its influence on OSCC lymphangiogenesis and metasta...
Tian-Jiao Li, Zhi-Chao Dou, Mao Li et al.· Oncogenesis· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.